HOCK E TAN, the President and CEO of $AVGO, sold 4,257 shares of the company on 12-23-2025 for an estimated $1,443,578. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.7% of their shares of this class of stock. Following this trade, they now own 591,381 shares of this class of $AVGO stock.
$AVGO Insider Trading Activity
$AVGO insiders have traded $AVGO stock on the open market 187 times in the past 6 months. Of those trades, 4 have been purchases and 183 have been sales.
Here’s a breakdown of recent trading of $AVGO stock by insiders over the last 6 months:
- HENRY SAMUELI has made 0 purchases and 16 sales selling 689,113 shares for an estimated $252,917,774.
- HOCK E TAN (President and CEO) has made 0 purchases and 16 sales selling 478,154 shares for an estimated $160,784,807.
- MARK DAVID BRAZEAL (Chief Legal & Corp Affairs Ofc) has made 0 purchases and 58 sales selling 90,012 shares for an estimated $30,496,501.
- KIRSTEN M. SPEARS (CFO & Chief Accounting Officer) has made 0 purchases and 44 sales selling 18,412 shares for an estimated $6,372,620.
- CHARLIE B KAWWAS (President, Semi Solutions Grp) has made 0 purchases and 43 sales selling 9,560 shares for an estimated $3,309,571.
- JUSTINE PAGE has made 0 purchases and 6 sales selling 4,800 shares for an estimated $1,587,952.
- HARRY L. YOU has made 4 purchases buying 4,550 shares for an estimated $1,552,999 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$AVGO Hedge Fund Activity
We have seen 2,095 institutional investors add shares of $AVGO stock to their portfolio, and 1,950 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 31,423,170 shares (+78.8%) to their portfolio in Q3 2025, for an estimated $10,366,818,014
- CAPITAL WORLD INVESTORS removed 12,713,939 shares (-8.6%) from their portfolio in Q3 2025, for an estimated $4,194,455,615
- WELLINGTON MANAGEMENT GROUP LLP removed 10,906,362 shares (-19.0%) from their portfolio in Q3 2025, for an estimated $3,598,117,887
- NORGES BANK removed 5,462,267 shares (-7.5%) from their portfolio in Q2 2025, for an estimated $1,505,673,898
- BNP PARIBAS FINANCIAL MARKETS removed 5,416,301 shares (-47.9%) from their portfolio in Q3 2025, for an estimated $1,786,891,862
- BANK OF AMERICA CORP /DE/ removed 5,123,905 shares (-7.6%) from their portfolio in Q3 2025, for an estimated $1,690,427,498
- PRICE T ROWE ASSOCIATES INC /MD/ added 4,904,436 shares (+6.3%) to their portfolio in Q3 2025, for an estimated $1,618,022,480
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$AVGO Revenue
$AVGO had revenues of $18B in Q4 2025. This is an increase of 28.18% from the same period in the prior year.
You can track AVGO financials on Quiver Quantitative's AVGO stock page.
$AVGO Congressional Stock Trading
Members of Congress have traded $AVGO stock 18 times in the past 6 months. Of those trades, 12 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $AVGO stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 11/18, 10/17 and 0 sales.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
- REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 3 purchases worth up to $80,000 on 10/10 and 0 sales.
- REPRESENTATIVE VAL T. HOYLE sold up to $50,000 on 09/23.
- REPRESENTATIVE CLEO FIELDS has traded it 6 times. They made 6 purchases worth up to $315,000 on 09/17, 08/15, 08/13, 07/29, 07/18 and 0 sales.
- SENATOR SHELLEY MOORE CAPITO sold up to $15,000 on 07/18.
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
- REPRESENTATIVE JAMES COMER sold up to $15,000 on 07/03.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$AVGO Analyst Ratings
Wall Street analysts have issued reports on $AVGO in the last several months. We have seen 16 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 12/12/2025
- Benchmark issued a "Buy" rating on 12/12/2025
- Piper Sandler issued a "Overweight" rating on 12/12/2025
- Bernstein issued a "Outperform" rating on 12/12/2025
- Rosenblatt issued a "Buy" rating on 12/12/2025
- Oppenheimer issued a "Outperform" rating on 12/12/2025
- Morgan Stanley issued a "Overweight" rating on 12/01/2025
To track analyst ratings and price targets for $AVGO, check out Quiver Quantitative's $AVGO forecast page.
$AVGO Price Targets
Multiple analysts have issued price targets for $AVGO recently. We have seen 22 analysts offer price targets for $AVGO in the last 6 months, with a median target of $450.0.
Here are some recent targets:
- William Stein from Truist Securities set a target price of $510.0 on 12/19/2025
- Timothy Arcuri from UBS set a target price of $475.0 on 12/15/2025
- Stacy Rasgon from Bernstein set a target price of $475.0 on 12/12/2025
- Christopher Danely from Citigroup set a target price of $480.0 on 12/12/2025
- Joshua Buchalter from TD Cowen set a target price of $450.0 on 12/12/2025
- Cody Acree from Benchmark set a target price of $485.0 on 12/12/2025
- Harlan Sur from JP Morgan set a target price of $475.0 on 12/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
